Public Profile

Aurinia

Aurinia Pharmaceuticals Inc., commonly referred to as Aurinia, is a biopharmaceutical company headquartered in Canada. Founded in 2013, Aurinia focuses on developing innovative therapies for autoimmune diseases, with a particular emphasis on lupus nephritis. The company has made significant strides in the industry, notably with the launch of its flagship product, LUPKYNIS™ (voclosporin), which offers a unique mechanism of action that enhances treatment options for patients. With a strong presence in North America and expanding operations in Europe, Aurinia has established itself as a leader in the autoimmune disease sector. The company’s commitment to research and development, coupled with its strategic partnerships, has positioned it favourably in the market, earning recognition for its contributions to patient care and treatment advancements.

DitchCarbon Score

How does Aurinia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

5

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

13

Industry Benchmark

Aurinia's score of 5 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.

11%

Aurinia's reported carbon emissions

In 2023, Aurinia reported total carbon emissions of approximately 218,430 kg CO2e, a notable increase from about 198,740 kg CO2e in 2022. The emissions for 2022 were solely from Scope 2, indicating that the company has not reported any Scope 1 emissions. Despite the increase in total emissions, there are currently no disclosed reduction targets or climate pledges from Aurinia. This lack of specific commitments may reflect a broader industry context where many companies are still developing their climate strategies. Aurinia's headquarters in Canada positions it within a region increasingly focused on sustainability and emissions reduction, yet the absence of defined targets suggests an opportunity for the company to enhance its climate commitments moving forward.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

Add to project
2022
Scope 1
-
Scope 2
198,740
Scope 3
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Aurinia's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Aurinia is headquartered in CA, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Aurinia is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Medical Device Manufacturing

Concept Laser GmbH

DE
Medical Device Manufacturing
Updated 3 days ago

Ten Seven Nine Design Ltd

DE
Medical Device Manufacturing
Updated 8 days ago
CDP

Pharmaceutical Technology

GB
Medical Device Manufacturing
Updated 11 days ago

Fritz Ruck Ophthalmologische Systeme GmbH

DE
Medical Device Manufacturing
Updated 3 days ago

Kopran

IN
Medical Device Manufacturing
Updated 11 days ago

Nipro

BE
Medical Device Manufacturing
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers